Sanofi Is Now the Third Insulin Producer to Slash Prices:
time.com/6264077/sanofi-insulin-price-cuts/
Story Details
| Last Updated | Mar 17 23 |
| Total Articles | 3 |
News on this topic
Sanofi is the latest insulin maker to announce price cap: Sanofi joins Eli Lilly and Novo Nordisk to cap insulin prices. President Joe Biden still wants Congress ...
scrippsnews.com/stories/sanofi-now-among-companies-capping-insulin-prices/
The biggest U.S. pharmaceutical companies are lowering insulin costs to save themselves money
axios.com/2023/03/17/sanofi-insulin-price-cap-rebate-medicaid
More articles on this subject
Previous
Sanofi is the latest insulin maker to announce price cap: Sanofi joins Eli Lilly and Novo Nordisk to cap insulin prices. President Joe Biden still wants Congress ...
scrippsnews.com/stories/sanofi-now-among-companies-capping-insulin-prices/
The biggest U.S. pharmaceutical companies are lowering insulin costs to save themselves money
axios.com/2023/03/17/sanofi-insulin-price-cap-rebate-medicaid
US Senate committee investigates pricing of Novo's Ozempic and Wegovy: A U.S. Senate committee said on Wednesday it had launched an investigation into the prices ...
reuters.com/business/healthcare-pharmaceuticals/us-senate-committee-investigates-pricing-novos-ozempic-wegovy-2024-04-24/
Sanofi (SAN FP) Asks Banks to Pitch Roles for $20 Billion OTC Spinoff: French drugmaker Sanofi has asked banks to pitch for roles on the separation of its ...
bloomberg.com/news/articles/2024-04-23/sanofi-is-said-to-ask-banks-to-pitch-for-20-billion-otc-spinoff
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy: Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss ...
nytimes.com/2024/04/20/business/ozempic-novo-nordisk-wegovy.html
German watchdog approves Novo's acquisition of Cardior Pharmaceuticals: The German cartel office has approved a deal by Denmark's Novo Nordisk to purchase ...
reuters.com/business/healthcare-pharmaceuticals/german-watchdog-approves-novos-acquisition-cardior-pharmaceuticals-2024-04-18/
Plaintiffs' lawyers chosen to lead Ozempic litigation: A federal judge has appointed eight plaintiffs' lawyers to leadership roles in federal mass tort ...
reuters.com/legal/litigation/plaintiffs-lawyers-chosen-lead-ozempic-litigation-2024-04-24/
Bankruptcy allowed Mallinckrodt to end Acthar royalties, 3rd Circ. rules: Mallinckrodt's bankruptcy permitted the drug company to end a perpetual royalty ...
reuters.com/legal/litigation/bankruptcy-allowed-mallinckrodt-end-acthar-royalties-3rd-circ-rules-2024-04-25/
India's Biocon developing its own version of Wegovy, clinical trial likely next year
reuters.com/business/healthcare-pharmaceuticals/indias-biocon-developing-its-own-version-wegovy-clinical-trial-likely-next-year-2024-04-18/
Quick Glance: Biocon Developing Own Version of Wegovy, Plans Clinical Trial
- Indian pharmaceutical company Biocon is working on developing its own version of Novo Nordisk's popular Wegovy and is likely to conduct a clinical trial next year to enter the growing weight-loss drug market.
- Biocon's CEO, Siddharth Mittal, has expressed the company's intention to develop semaglutide, the active ingredient in Wegovy, for the Indian market, even if it requires a clinical trial.
- Biocon aims to introduce generic versions of weight-loss drugs in emerging markets such as Brazil, Mexico, and Saudi Arabia before the patent for semaglutide expires in those countries in 2026.
- The company is striving to obtain a waiver on clinical trials from Indian regulators and submit bioequivalence studies to demonstrate the effectiveness of their version of semaglutide. Biocon is making significant investments in generics research and development, including peptides for weight-loss drugs.
The weight loss drug Ozempic is not linked to suicidal thoughts, regulators say: The European Medicines Agency announced the findings of its nine-month review
qz.com/ema-ozempic-suicidal-thoughts-1851406145
Bullish signal for biotech shares: Will this solve one of Novo Nordisk's biggest problems?
boerse-online.de/nachrichten/aktien/bullisches-signal-fuer-biotech-aktie-loest-das-eines-der-groessten-probleme-von-novo-nordisk-20355342.html
Medicare beneficiaries could be eligible for Wegovy coverage, study shows
reuters.com/business/healthcare-pharmaceuticals/about-36-mln-medicare-beneficiaries-could-be-eligible-wegovy-coverage-study-2024-04-24/
EU regulator to review reports of suicidal thoughts and weight loss drugs: A European Medicines Agency committee will this week hold a meeting related to its ...
reuters.com/business/healthcare-pharmaceuticals/eu-health-regulator-discuss-any-link-between-weight-loss-drugs-suicidal-thoughts-2024-04-08/
Novo Nordisk may buy German biotech company Cardior: The German biotech company Cardior is researching an active ingredient against heart failure and is now ...
diepresse.com/18385607/novo-nordisk-darf-deutsche-biotech-firma-cardior-kaufen
Novo Nordisk parent refiles US application on Catalent deal: The parent of Wegovy producer Novo Nordisk has refiled an application to the U.S ...
reuters.com/markets/deals/novo-nordisk-parent-refiles-us-application-catalent-deal-2024-04-08/
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
cnbc.com/2024/04/20/weight-loss-drug-patients-spend-less-on-restaurants-takeout-survey.html
Drug sales keep beating Wall Street's expectations and boosting some pharma stocks
qz.com/pharma-sales-q1-1851435519
Popular weight loss drugs in tight supply as Zepbound shortage could last through June
abcnews.go.com/Health/popular-weight-loss-drugs-tight-supply-zepbound-shortage/story
Hundreds of websites have been hawking fake Ozempic and other weight loss drugs. More may be coming
qz.com/fake-ozempic-websites-shut-down-1851411488
Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know
fastcompany.com/91110090/metsera-startup-eli-lilly-novo-nordisk-competitor-weight-loss-drugs
Biocon leads India push into weight loss drugs as patents lapse: The Bengaluru-based firm is pivoting to anti-obesity therapies as patents for the blockbuster ...
dailymaverick.co.za/article/2024-04-08-biocon-leads-india-push-into-weight-loss-drugs-as-patents-lapse/
Eli Lilly vs. Novo Nordisk: Is this biotech stock ahead thanks to just one number?
boerse-online.de/nachrichten/aktien/eli-lilly-vs-novo-nordisk-hat-diese-biotech-aktie-dank-nur-einer-zahl-die-nase-vorn-20354696.html
Costco enters a controversial industry with its latest move: Costco is expanding one of its beloved programs to include coverage of a growing trend that has ...
thestreet.com/retail/costco-enters-a-controversial-industry-with-its-latest-move
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
reuters.com/business/healthcare-pharmaceuticals/abbvies-skin-disease-drug-found-be-more-effective-than-regenerons-dupixent-study-2024-04-25/
Bernie Sanders Is Taking on Ozempic’s ‘Astronomically High’ Price Tag: The Vermont senator is launching an investigation into why these game-changing diabetes ...
gizmodo.com/bernie-sanders-investigation-ozempic-high-cost-1851438517
Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead: Novo Nordisk A/S’s reign as Europe’s most valuable company “leaves no room to disappoint” with its ...
bloomberg.com/news/articles/2024-04-26/novo-reigns-stellantis-resilient-emea-earnings-week-ahead
Paid articlePaid
Ozempic ‘oops’ babies spark debate about weight-loss shot use as fertility drugs: A surprising thing is happening to some women on weight-loss drugs who’ve ...
bostonherald.com/2024/04/22/ozempic-oops-babies-spark-debate-about-weight-loss-shot-use-as-fertility-drugs/
AstraZeneca, Sanofi Bolt Higher On Quarterly Beats, But Bristol Myers Dives: AstraZeneca soundly topped analysts' views while Sanofi narrowed its losses.
investors.com/news/technology/astrazeneca-stock-bristol-myers-squibb-sanofi-earnings-q1-2024/
Sanofi (SAN) Posts Strong Sales Growth With New Hemophilia Medicine: Sanofi posted first-quarter revenue that exceeded estimates as strong demand for its new ...
bloomberg.com/news/articles/2024-04-25/sanofi-posts-strong-sales-growth-with-new-hemophilia-medicine
Paid articlePaid
Medicines Agency: No Ozempic pregnancies in the EU: According to the European Medicines Agency, there are no cases of surprise pregnancies caused by Ozempic in ...
profil.at/wissenschaft/arzneimittelagentur-keine-ozempic-schwangerschaften-in-der-eu/402870968
Is the weight loss injection expensive hype or the big breakthrough?: We talk to doctor Harald Schneider and F.A.Z. editor Lucia Schmidt about the weight loss ...
faz.net/podcasts/f-a-z-podcast-fuer-deutschland/ist-die-abnehmspritze-teurer-hype-oder-der-grosser-durchbruch-19675445.html
Paid articlePaid
Bay Area tech layoffs: Cancer screening company to cut 20% of workers: Bay Area tech layoffs: South San Francisco cancer screening company to cut 20% of ...
sfchronicle.com/bayarea/article/tech-layoffs-freenome-19421173.php
Paid articlePaid
How one state is trying to make weight loss drugs cheaper: Weight loss drugs aren't covered by insurance for North Carolina's state employees ...
nbcnews.com/health/health-news/one-state-trying-make-weight-loss-drugs-cheaper-rcna148997
Run on new weight loss drugs: "Many don't even want their partner to know": Injections from Novo Nordisk and Eli Lilly promise quick slimming on prescription ...
spiegel.de/wirtschaft/unternehmen/wegovy-mounjaro-und-co-kommt-nach-der-abnehmspritze-bald-die-schlankheitspille-a-8d2b1f3f-ec7c-4888-86ae-5494aab96f0e
SHAREHOLDER hot stock Gubra: New arrow against pounds in the quiver: Another source of hope in the Danes' pipeline.
deraktionaer.de/artikel/pharma-biotech/aktionaer-hot-stock-gubra-neuer-pfeil-gegen-pfunde-im-koecher-20355945.html
Paid articlePaid
Equity funds: How SAP makes life difficult for fund managers: The rise of megacaps such as Microsoft, Novo Nordisk and SAP is increasingly becoming a problem for ...
capital.de/geld-versicherungen/aktienfonds--wie-sap-fondsmanagern-das-leben-schwer-macht-34650416.html
Paid articlePaid Sanofi to Pay $100 Million to Settle Zantac Cancer Lawsuits: Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker ...
bloomberg.com/news/articles/2024-04-22/sanofi-to-pay-100-million-to-settle-zantac-cancer-lawsuits
Paid articlePaid
Novo Nordisk Remains The Better Buy After A Moderate Pullback: Novo Nordisk (NVO) continues to be rated as a Buy, with the stock already charting an impressive ...
seekingalpha.com/article/4685043-novo-nordisk-better-buy-after-moderate-pullback
Paid articlePaid Ozempic's latest reported side effect: pregnancy: A number of women are reporting unplanned pregnancies while taking drugs like Ozempic.
axios.com/2024/04/18/ozempic-pregnancy-weight-loss-drugs-fertility-report
FDI in Waterford: Sanofi’s strong partnership with the southeast: Sanofi is one of the largest employers in the southeast, and site head Amy Brennan says the ...
businesspost.ie/commercial-reports/fdi-in-waterford-sanofis-strong-partnership-with-the-southeast/
Sanofi to cut 99 jobs in Belgium
brusselstimes.com/business/1015619/sanofi-to-cut-99-jobs-in-belgium
Ozempic Babies: Doctors Want Safety Data on Obesity Shots During Pregnancy: A surprising thing is happening to some women on weight-loss drugs who’ve struggled ...
bloomberg.com/news/articles/2024-04-18/ozempic-babies-doctors-want-safety-data-on-obesity-shots-during-pregnancy
Even more doses of Eli Lilly's Zepbound and Mounjaro are officially in a shortage, FDA says
qz.com/eli-lilly-zepbound-shortage-fda-1851416991
Hanover: Federal Cartel Office approves Cardior takeover: The competition authority has no objections to the new owner Novo Nordisk. The Danes want to buy the ...
neuepresse.de/wirtschaft/regional/hannover-bundeskartellamt-genehmigt-cardior-uebernahme-XW42UM2WENCUFIMJY5IDDCXGEQ.html
Paid articlePaid One time chance? Eli Lilly and Novo Nordisk shares have even more potential than expected
boerse-online.de/nachrichten/aktien/einmalige-chance-die-aktien-von-eli-lilly-und-novo-nordisk-haben-noch-mehr-potenzial-als-gedacht-20355579.html
Federal Cartel Office approves purchase of Cardior: Hanover - The Danish pharmaceutical company Novo Nordisk is allowed to buy the biotech company Cardior ...
dlvr.it/T5kfLq
Eight stock picks in AI, obesity drugs and other growth areas beyond the S&P 500: Nicole Kornitzer of Buffalo Funds explains how she invests in ‘secular growth ...
marketwatch.com/story/eight-stock-picks-in-ai-obesity-drugs-e-commerce-and-other-growth-areas-beyond-the-s-p-500-1f84da89
U.S. Stocks Have Outperformed Europe for Years. Why That Could Change for a While.
barrons.com/articles/u-s-stocks-have-outperformed-europe-for-years-why-that-could-change-for-a-while-bf7f2ede
Paid articlePaid Costco enters a controversial industry with its latest move: Costco is expanding one of its beloved programs to include coverage of a growing trend that has ...
thestreet.com/retail/costco-enters-a-controversial-industry-with-its-latest-move
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports: The company reported results of clinical trials involving Zepbound, an obesity drug in the ...
nytimes.com/2024/04/17/health/sleep-apnea-obesity-zepbound.html
Copenhagen's Børsen Tower Can Rise Again With Novo Nordisk's Help: Denmark should take lessons from the fire at Notre Dame — and how French luxury ...
bloomberg.com/opinion/articles/2024-04-16/copenhagen-s-ravaged-stock-exchange-can-rise-again-with-novo-nordisk-help
Paid articlePaid
Stigmatization affects the psychology of people with obesity: Every year, Novo Nordisk highlights a special topic from the complex clinical picture of obesity in ...
medical-tribune.de/medizin-und-forschung/artikel/die-unsichtbare-last-des-stigmas
Cardior bosses: “The market for our new drug is huge”: 65 million people worldwide suffer from heart failure. The Hanover company Cardior has developed a new ...
neuepresse.de/wirtschaft/regional/cardior-chefs-der-markt-fuer-unser-neues-medikament-ist-riesig-EQCAWCCSWJDGTOTSVFQV3CIGVA.html
Paid articlePaid
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
fortune.com/europe/2024/04/10/astrazeneca-boss-pascal-soriot-pay/
Paid articlePaid Obesity-drug power duo Novo Nordisk and Eli Lilly have room to run, analysts say: BMO analysts cut price target for Amgen, another contender in the weight-loss ...
marketwatch.com/story/obesity-drug-power-couple-novo-nordisk-and-eli-lilly-still-have-room-to-run-analysts-say-c37743b9
Costco enters a controversial industry with its latest move: The retail giant is expanding one of its beloved programs to include a growing trend.
charlotteobserver.com/news/business/article287364065.html
Ozempic slimming injection: How pharmaceutical companies play patients off against each other
berliner-zeitung.de/open-source/abnehmspritze-ozempic-wie-pharmakonzerne-patienten-gegeneinander-ausspielen-li.2203936
Eli Lilly (LLY), Novo (NOVOB DC) Risk Missing High Expectations, Goldman Says: The weight loss drug frenzy that’s driven Eli Lilly & Co. and Novo Nordisk A/S ...
bloomberg.com/news/articles/2024-04-12/lilly-novo-euphoria-risks-disappointing-investors-goldman-says
Paid articlePaid Genentech and Sanofi to lay off hundreds of Bay Area employees: Biotech giants Genentech and Sanofi are set to lay off hundreds of Bay Area workers in the coming ...
sfchronicle.com/bayarea/article/genentech-sanofi-layoffs-bay-area-19399610.php
AstraZeneca there: That's why these biotech stocks are now making hearts beat faster on Wall Street
boerse-online.de/nachrichten/aktien/astrazeneca-dabei-darum-lassen-diese-biotech-aktien-an-der-wall-street-jetzt-herzen-hoeher-schlagen--20354827.html
How the 'Oh-Oh-Oh Ozempic' Commercial Song Made a Musician $1 Million: David Paton's 1974 song "Magic" has been repurposed as the theme ...
entrepreneur.com/business-news/ozempic-song-used-in-commercial-makes-70s-rockers-millions/472492
Novo Nordisk: Deal with Ginkgo Bioworks is expanded - the details: The Danes are further expanding their partnership with the synthetic biology specialist.
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-deal-mit-ginkgo-bioworks-wird-erweitert-die-details-20354834.html
Wegovy’s heart benefits are not just linked with weight loss, new study suggests: Heart-failure patients with diabetes may shed fewer pounds on Wegovy but still ...
marketwatch.com/story/wegovys-heart-benefits-are-not-just-linked-with-weight-loss-new-study-suggests-1bfcf903
Meet Europe’s Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.
barrons.com/articles/novo-nordisk-asml-lvmh-nestle-european-mag-stocks-554d95c7
Paid articlePaid Novo Nordisk: The Moat Won't Last Forever: Novo Nordisk is currently the preeminent player in this burgeoning GLP-1 market space. Click here to read an analysis ...
seekingalpha.com/article/4682909-novo-nordisk-the-moat-wont-last-forever
Paid articlePaid Eli Lilly's weight loss injection: explosive device for the German health system: Eli Lilly, the largest pharmaceutical company in the world, will soon be ...
capital.de/wirtschaft-politik/eli-lillys-abnehmspritze--sprengsatz-fuers-deutsche-gesundheitssystem-34607690.html
I Invested in Ozempic—It Taught Me a Valuable Lesson: It is now more valuable than Tesla.
newsweek.com/i-invested-ozempic-it-taught-me-valuable-lesson-1887867
Costco is now prescribing Ozempic, Wegovy, and other weight loss drugs: The warehouse club is offering prescriptions for weight loss drugs through its health ...
qz.com/costco-ozempic-wegovy-weight-loss-drugs-prescription-1851382263
Paid articlePaid
Drugmaker seeks approval for China's first biosimilar Ozempic: A drugmaker in China has developed a biosimilar version of Novo Nordisk's popular diabetes drug ...
reuters.com/business/healthcare-pharmaceuticals/chinas-first-biosimilar-ozempic-drug-applies-approval-2024-04-03/
Why A Pullback Is Bullish For IBD Stock Of The Day Novo Nordisk: Novo Nordisk is Friday's IBD Stock Of The Day. After hitting a record high in March ...
investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-pullback-weight-loss-drugs/
Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data
seekingalpha.com/article/4681317-why-eli-lilly-and-rival-novo-nordisk-wont-be-troubled-by-vikings-latest-weight-loss-data
Paid articlePaid More than 65% upside: Is this unknown biotech stock now making Novo Nordisk and co. sweat?
boerse-online.de/nachrichten/aktien/mehr-als-65-upside-bringt-diese-unbekannte-biotech-aktie-novo-nordisk-und-co-jetzt-zum-schwitzen-20354064.html
The Ozempic boom: How the entire country of Denmark became a company town: Economists warn of “Nokia-style” overdependence on a single sector.
politico.eu/article/ozempic-boom-entire-country-kalundborg-denmark-became-company-town-pharma-novo-nordisk/
The race to develop the next generation of weight-loss drugs: Novo Nordisk and Eli Lilly, plus a clutch of rivals, aim to cut side effects while treating ...
ft.com/content/864631da-24d2-4d18-96b2-d2cb450edd5b
Paid articlePaid Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
cnbc.com/2024/04/04/danone-ceo-downplays-threat-of-weight-loss-drugs-on-food-producers.html
Ozempic's cheaper side, weight loss drug competition, and Amazon delivery: Pharma news roundup
qz.com/ozempic-weight-loss-drug-amazon-delivery-novo-nordisk-1851373018
Paid articlePaid Ozempic costs just $5 to make, a study said. The backlash was swift: Novo Nordisk is facing pressure after a study revealed low production costs for its popular ...
qz.com/ozempic-price-backlash-study-sanders-1851374290
Paid articlePaid Johnson & Johnson just bought a second big heart device company: The healthcare giant has agreed to acquire Shockwave Medical in a $13.1 billion deal
qz.com/johnson-and-johnson-shockwave-medical-acquisition-1851390357
Eli Lilly's weight loss drug Zepbound is officially in a shortage: The FDA says some doses of the drug will be in limited supply until the end of April
qz.com/weight-loss-drug-zepbound-fda-shortage-eli-lilly-1851384557
Paid articlePaid
Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And Expand -
benzinga.com/analyst-ratings/analyst-color/24/04/38055169/citi-monitors-competitive-threats-to-eli-lilly-says-it-is-positioned-to-maintain-le
Ozempic and Wegovy: How dangerous is the weight loss injection?: The weight loss injection is considered a new miracle cure. Losing pounds has never been easier ...
augsburger-allgemeine.de/kultur/gesellschaft/ozempic-und-wegovy-wie-gefaehrlich-ist-die-abnehmspritze-id69853691.html
Paid articlePaid Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics